Early goal directed therapy in ED sepsis patients is cost effective

In this analysis of several hundred patients at one institution before and after the initiation of early goal directed therapy for sepsis patients in the ED, although the overall costs were higher after initiation, it was found to be cost-effective with a mean increase in 1.3 QALYs (for a cost of about $5,400 per QALY, far below the typical US standard of $50,000). (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment